HEXIM2, a HEXIM1-related protein, regulates positive transcription elongation factor b through association with 7SK

被引:95
作者
Byers, SA
Price, JP
Cooper, JJ
Li, QT
Price, DH
机构
[1] Univ Iowa, Dept Biochem, Iowa City, IA 52242 USA
[2] Univ Iowa, Program Mol Biol, Iowa City, IA 52242 USA
关键词
D O I
10.1074/jbc.M500424200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The kinase activity of positive transcription elongation factor b (P-TEFb), composed of cyclin-dependent kinase 9 and cyclin T1 or T2, is required for the transition of RNA polymerase II into productive elongation. P-TEFb activity has been shown to be negatively regulated by association with the small nuclear RNA 7SK and the HEXIM1 protein. Here, we characterize HEXIM2, a previously predicted protein with sequence similarity to HEXIM1. HEXIM2 is expressed in HeLa and Jurkat cells, and glycerol gradient analysis and immunoprecipitations indicate that HEXIM2, like HEXIM1, has a regulated association with P-TEFb. As HEXIM1 is knocked down, HEXIM2 functionally compensates for its association with P-TEFb. Electrophoretic mobility shift assays and in vitro kinase assays demonstrate that HEXIM2 forms complexes containing 7SK and P-TEFb and, in conjunction with 7SK, inhibits P-TEFb kinase activity. Our results provide strong evidence that HEXIM2 is a regulator of P-TEFb function. Furthermore, our results support the idea that the utilization of HEXIM1 or HEXIM2 to bind and inhibit P-TEFb can be differentially regulated in vivo.
引用
收藏
页码:16360 / 16367
页数:8
相关论文
共 42 条
[1]   NF-κB binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II [J].
Barboric, M ;
Nissen, RM ;
Kanazawa, S ;
Jabrane-Ferrat, N ;
Peterlin, BM .
MOLECULAR CELL, 2001, 8 (02) :327-337
[2]   Pharmacogenomic identification of targets for adjuvant therapy with the topoisomerase poison camptothecin [J].
Carson, JP ;
Zhang, NY ;
Frampton, GM ;
Gerry, NP ;
Lenburg, ME ;
Christman, MF .
CANCER RESEARCH, 2004, 64 (06) :2096-2104
[3]   Flavopiridol inhibits P-TEFb and blocks HIV-1 replication [J].
Chao, SH ;
Fujinaga, K ;
Marion, JE ;
Taube, R ;
Sausville, EA ;
Senderowicz, AM ;
Peterlin, BM ;
Price, DH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (37) :28345-28348
[4]   Flavopiridol inactivates P-TEFb and blocks most RNA polymerase II transcription in vivo [J].
Chao, SH ;
Price, DH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (34) :31793-31799
[5]   Myc recruits P-TEFb to mediate the final step in the transcriptional activation of the cad promoter [J].
Eberhardy, SR ;
Farnham, PJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (42) :40156-40162
[6]   Relief of two built-in autoinhibitory mechanisms in P-TEFb is required for assembly of a multicomponent transcription elongation complex at the human immunodeficiency virus type 1 promoter [J].
Fong, YW ;
Zhou, Q .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (16) :5897-5907
[7]   Cyclin K functions as a CDK9 regulatory subunit and participates in RNA polymerase II transcription [J].
Fu, TJ ;
Peng, JM ;
Lee, G ;
Price, DH ;
Flores, O .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (49) :34527-34530
[8]   Cellular control of gene expression by T-type cyclin/CDK9 complexes [J].
Garriga, J ;
Graña, X .
GENE, 2004, 337 :15-23
[9]   Identification of a novel cardiac lineage-associated Protein(cCLP-1): A candidate regulator of cardiogenesis [J].
Ghatpande, S ;
Goswami, S ;
Mathew, S ;
Rong, G ;
Cai, L ;
Shafiq, S ;
Siddiqui, MAQ .
DEVELOPMENTAL BIOLOGY, 1999, 208 (01) :210-221
[10]   Structure, expression, and functional characterization of the mouse CLP-1 gene [J].
Huang, FC ;
Wagner, M ;
Siddiqui, MAQ .
GENE, 2002, 292 (1-2) :245-259